Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Netherlands Cancer Institute

www.nki.nl

Latest From Netherlands Cancer Institute

Tech Transfer Roundup: Neon Licenses NKI IP To Advance Cell Therapy Into Clinic

Continuing a partnership between Neon co-founder and two Netherlands Cancer Institute researchers, agreement will help autologous T-cell candidate move into Phase I. Plus Scrip's monthly roundup of tech transfer deals.

Deals StartUps and SMEs

Neon Looks To Pioneer Neoantigen Space

With Third Rock partners in executive roles, a personalized vaccine will go into clinical development in 2016, but Neon also plans to develop a personalized T-cell therapy and off-the-shelf vaccines and T-cell therapies based on groundbreaking neoantigen biology.

BioPharmaceutical United States

Deals Shaping The Medical Industry, April 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced March 2015.

BioPharmaceutical Medical Device

Bristol-Myers Taps Academia To Help Research Immuno-Oncology Pipeline

Inspired by the correlative research during the clinical trials for Yervoy, BMS teams up with ten institutions from across the globe to find biomarkers in post-response data.

BioPharmaceutical Clinical Trials
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register